Pharmacokinetics and Safety of Moxifloxacin in Children With Multidrug-Resistant Tuberculosis

Background. Moxifloxacin is currently recommended at a dose of 7.5–10 mg/kg for children with multidrug-resistant (MDR) tuberculosis, but pharmacokinetic and long-term safety data of moxifloxacin in children with tuberculosis are lacking. An area under the curve (AUC) of 40–60 µg × h/mL following an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Thee, Stephanie, Garcia-Prats, Anthony J., Draper, Heather R., McIlleron, Helen M., Wiesner, Lubbe, Castel, Sandra, Schaaf, H. Simon, Hesseling, Anneke C.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4366580/
https://ncbi.nlm.nih.gov/pubmed/25362206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu868
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars